Is the swine flu going to be pandemic?

I still contend we are all far more likely to die from the next time we get into a car than from a flu pandemic. Unless you live in Mexico or frequent hospitals, I wouldn't lose any sleep over this

That's why there are seat belts and crash protections in vehicles and this is a form of the same for millions if not billions of people worldwide.

IF a deadly outbreak gets contained - as it did with SARs - it's the difference between a single car collision and the San Francisco skyway collapsing. It's money well spent by society just as with other real risks ( fear of man in tent is not and look what's spent on that ).

Agreed - don't chew nails - it's not productive,
DO think about what action you and your family might take if the threat materializes.
I have two at risk immune systems in the household and another staffer in the same situation. It bears watching and understanding.
 
OTOH, there is no reason to think a vaccine will not work...
There is arguably no more reason to think a vaccine against this strain will not work than there is to think that a particular component of a seasonal vaccine will not work against the strain it targets. When that strain finally arrives all those months after development of the seed stock began. And assuming that nothing goes wrong during the rather tricky manufacturing process. Vaccination offers many possibilities, but few guarantees.

... and one will be developed by next winter. I see nothing that is going to result in a decision not to go ahead with a vaccine.
I would have thought so too, but I've read transcripts of every CDC press release, and the matter is invariably couched in terms such as:

"In the event that we do want to implement a vaccination program in the fall..."

and:

"if we go forward with a vaccine..."

A panel of experts will advise the WHO on Wednesday, and a decision should follow soon after that.

Others are weighing in as well:

Need for flu vaccine is questioned

And then there is this awkward issue:

Vaccine would be spoken for

For the southern hemisphere there are some logistical problems, but not for the northern hemisphere where our seasonal vaccine production is almost completed. Our manufacturing capacity is soon to be freed up.
Actually, there is a bit of a snag.

"Reagents to test the concentration of influenza B component of the vaccine are not yet ready, leaving manufacturers unclear if they have enough to make all the trivalent - triple component - vaccine they have been contracted to make."

If they call up to ask for my input, I'll advise them to dump the B component, get cracking on the S-OIV vax, and kill all the lawyers.
 
They do enjoy some protection from liability claims, but I don't know about breach of contract.
 
All pandemic strains are A type influenza viruses which are of avian origin. There has to be a bird involved somewhere, and the second host is the mixing pot. Should there be a "not" in there where I emboldened it?
All strains of influenza virus, A, B and C including all the H and N variables exist in birds. That is why it is believed flu originated in birds. However, once the strains adapt to different species, they produce different surface proteins that favor different host cells. There has been evidence HPAI H5N1 has infected some swine, but it remains uncommon.

The new reassorted swine flu H1N1 contains genes that have been seen circulating in swine since the early 90s. These genes (with their identifiable mutation pattern) have not been found frequently circulating in birds. But then, they haven't been found frequently circulating in humans until now.

It isn't known what about this combination of genes has made this new strain so readily infect humans. I'm sure the researchers will soon sort that out. In the meantime, we see it remains capable of infecting pigs since a Canadian herd has now been infected with it. Cross your fingers that it is not also readily adapted to any species the H5N1 is well adapted to.


As for the (not), no, (low infectivity) yes, but not (not).

Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses.
Pigs had low susceptibility to infection with H5N1 HPAI viruses. Inoculation of pigs with H5N1 viruses resulted in asymptomatic to mild symptomatic infection restricted to the respiratory tract and tonsils in contrast to mouse and ferrets animal models, where some of the viruses studied were highly pathogenic and replicated systemically.

Of course mild symptoms can be a two edged sword. There could be unrecognized H5N1 circulating in those backyard pigs. And the pigs are in the same backyards as the chickens and ducks and the people.
 
Last edited:
I still contend we are all far more likely to die from the next time we get into a car than from a flu pandemic. Unless you live in Mexico or frequent hospitals, I wouldn't lose any sleep over this one.
Actually, Mexico has an atrocious vehicle related fatality rate that I'm pretty sure exceeds that of their flu deaths even with this epidemic.

And yes, the total annual deaths from vehicular accidents exceeds flu deaths in both countries. Familiarity tends to lower risk perception. Since both causes of death are so familiar to us, we ignore them to a great extent. Think about the number of people who died on 9/11 compared to these two annual death rates.

I'm not hiding in my bunker, if that's what you are implying by paying attention to the epidemic.

Just because people ignore these causes of preventable deaths is no reason to just write this new circulating strain off as non-news worthy. This is a good chance to educate the public about the risk of flu, a vaccine preventable disease.
 
Ared vaccine manufacturers not protected by law?
The vaccine injury compensation fund applies to vaccines given to children. Because flu vaccine is given to children, it has been included. It's like no fault insurance.

It applies in the US. I don't know what other countries have on their books, though.

National Vaccine Injury Compensation Program
The Vaccine Injury Compensation Trust Fund (Trust Fund) provides funding for the National Vaccine Injury Compensation Program (VICP) to compensate vaccine-related injury or death claims for covered vaccines administered on or after October 1, 1988. The Trust Fund is funded by a $0.75 excise tax on each dose of vaccine purchased (i.e., each disease prevented in a dose of vaccine). For example, the excise tax imposed on a dose of trivalent influenza vaccine is $0.75 because it prevents one disease, whereas the excise tax imposed on a dose of the measles-mumps-rubella vaccine is $2.25 because prevents three diseases. The taxable vaccines have also been recommended by the Centers for Disease Control and Prevention (CDC) for routine administration to children.

The Department of Treasury collects the excise taxes, and oversees and manages the investing activities for the Trust Fund. As of January 31, 2007, the Trust Fund balance was nearly $2.5 billion. The Trust Fund monthly reports are available on the Treasury’s Bureau of Public Debt Website.
Covered Vaccines

The following vaccines are covered by the VICP:

* Diphtheria, tetanus, pertussis (DTP, DTaP, Tdap, DT, Td, or TT)

* Haemophilus influenzae type b (Hib)

* Hepatitis A (HAV)

* Hepatitis B (HBV)

* Human papillomavirus (HPV)

* Influenza (TIV, LAIV) [given each year during the flu season]

* Measles, mumps, rubella (MMR, MR, M, R)

* Meningococcal (MCV4, MPSV4)

* Polio (OPV or IPV)

* Pneumococcal conjugate (PCV)

* Rotavirus (RV)

* Varicella (VZV)

* Any combination of the vaccines above

* Additional vaccines may be added in the future
 
The issue raised by the link I posted above:
Vaccine may be spoken for
may need a little clarifying for those who didn't read the article. It has nothing to do with vaccine injury:

"Although no final decision has been made to produce a vaccine against the new strain of swine flu, officials at the World Health Organization say they are aware of "pre-production contracts" by wealthy countries that may lay claim to substantial quantities of any that is made.

The worldwide capacity for making a pandemic vaccine is 2 billion doses at the most and possibly as little as 1 billion doses, depending on the uncertainties involving production and dosage. Of that total, the United States has preexisting contracts that would allow it to buy at least 600 million doses."
 
....

I would have thought so too, but I've read transcripts of every CDC press release, and the matter is invariably couched in terms such as:

"In the event that we do want to implement a vaccination program in the fall..."

and:

"if we go forward with a vaccine..."
Of course. They speak in political tongue. They cannot be announcing plans to go forward until the plans are official. At this point, however, there is little question, they will go forward.

....A panel of experts will advise the WHO on Wednesday, and a decision should follow soon after that.

Others are weighing in as well:

Need for flu vaccine is questioned
The usual crap. One expects this kind of debate rhetoric, especially given the news media beats a path to the door of any 'expert' with a contradictory opinion. 'Experts' love their 15 minutes of fame.

....And then there is this awkward issue:

Vaccine would be spoken for
This has been an ongoing sore spot with Indonesia in particular. They held their H5N1 specimens for the ransom of some guarantee of getting in on the profits of a vaccine for H5N1. While they couch it as interest in getting their own citizens vaccinated (and there may be some political motivation for that) the government of Indonesia is notoriously profit motivated.

Of course, the third world is waking up and demanding more and more of their share of all the world's resources. This is just one more example. The developed nations can expect to see similar controversies in the years ahead.


....Actually, there is a bit of a snag.

"Reagents to test the concentration of influenza B component of the vaccine are not yet ready, leaving manufacturers unclear if they have enough to make all the trivalent - triple component - vaccine they have been contracted to make."

If they call up to ask for my input, I'll advise them to dump the B component, get cracking on the S-OIV vax, and kill all the lawyers.
It will be interesting to see the end results here. The discussion earlier was that the US manufacturers are mostly done with production. That article is from a Canadian source. I don't know if the US manufacturers are at a different production stage from Canadian and European sources or not.
 
The discussion earlier was that the US manufacturers are mostly done with production. That article is from a Canadian source. I don't know if the US manufacturers are at a different production stage from Canadian and European sources or not.
It's apparently quite a bit more complicated a matter than one might suppose. The WHO conducted a virtual press conference on it on May 6, during which that reporter, Helen Branswell, and others put some tough questions to WHO Director of the Initiative for Vaccine Research Dr. Marie-Paule Kieny.
Transcript

They go into it in some detail, but the only clear understanding I come away with regarding where production currently stands is that if anybody knows for sure, they aren't saying. Andy Pollack from NYT asked one question I would really have liked to hear an intelligible answer to: "I am interested in know what information will be come available between now and then that will lead to a decision NOT to go ahead with large scale manufacturing."

I've read through Kieny's response several times, and while I find most of it to be rather unenlightening, I have bolded a portion that does stand out for me:

"What might or might not come out of next week's meeting would be a recommendation that will be given to the Director-General and the Director-General will consider this and either issue or not. Usually she takes great consideration of advice and recommendations from this group. To recommend to manufacturers to produce large scale stocks of influenza A(H1N1) vaccine. The decision is not that of WHO as you know. The decision will be of the manufacturers to take. It is their prerogative to decide what they produce. So what information would be potentially available to say that is not yet the time? Well, it is a question of saying how this infection evolves. There are new data, new evidence coming every day about the epidemiological pattern, about the likely percentage of population who might be affected or at least be infected, about the severity of the disease."
 
It's apparently quite a bit more complicated a matter than one might suppose. The WHO conducted a virtual press conference on it on May 6, during which that reporter, Helen Branswell, and others put some tough questions to WHO Director of the Initiative for Vaccine Research Dr. Marie-Paule Kieny.
Transcript

They go into it in some detail, but the only clear understanding I come away with regarding where production currently stands is that if anybody knows for sure, they aren't saying. Andy Pollack from NYT asked one question I would really have liked to hear an intelligible answer to: "I am interested in know what information will be come available between now and then that will lead to a decision NOT to go ahead with large scale manufacturing."

I've read through Kieny's response several times, and while I find most of it to be rather unenlightening, I have bolded a portion that does stand out for me:

"What might or might not come out of next week's meeting would be a recommendation that will be given to the Director-General and the Director-General will consider this and either issue or not. Usually she takes great consideration of advice and recommendations from this group. To recommend to manufacturers to produce large scale stocks of influenza A(H1N1) vaccine. The decision is not that of WHO as you know. The decision will be of the manufacturers to take. It is their prerogative to decide what they produce. So what information would be potentially available to say that is not yet the time? Well, it is a question of saying how this infection evolves. There are new data, new evidence coming every day about the epidemiological pattern, about the likely percentage of population who might be affected or at least be infected, about the severity of the disease."
Is this a discussion of sharing information, or are you still trying to argue some point?

Of course the manufacturers are able to decide on their own. But in the case of the US manufacturers, they would not be investing in the vaccine if their largest buyer, the US Public Health Service aka the CDC did not make a formal recommendation to use the vaccine.

And as for who it will be recommended for, the ACIP (Advisory Committee for Immunization Practices) will spell that out for us. At this point, I can almost guarantee you, the vaccine will be made. And I can also guarantee you, it looks like the US will not be buying the 60 million doses because you can bet they are going to recommend the vaccine only for people with age and medical risk factors.

Occasionally the Europeans and Canadians have different recommendations on vaccines so I cannot predict with as much confidence what they will decide. I suspect they will do the same as the US does but one can never be too sure about a system one is less familiar with.

I am, however, very familiar with the US vaccine use and recommendations because for the last 19 years I have given thousands of doses of vaccines every year including between 1000-2000 flu shots and I take the time to know everything I can about vaccines I prescribe for that many people.
 
All strains of influenza virus, A, B and C including all the H and N variables exist in birds. That is why it is believed flu originated in birds. However, once the strains adapt to different species, they produce different surface proteins that favor different host cells. There has been evidence HPAI H5N1 has infected some swine, but it remains uncommon.

The new reassorted swine flu H1N1 contains genes that have been seen circulating in swine since the early 90s. These genes (with their identifiable mutation pattern) have not been found frequently circulating in birds. But then, they haven't been found frequently circulating in humans until now.

It isn't known what about this combination of genes has made this new strain so readily infect humans. I'm sure the researchers will soon sort that out. In the meantime, we see it remains capable of infecting pigs since a Canadian herd has now been infected with it. Cross your fingers that it is not also readily adapted to any species the H5N1 is well adapted to.


As for the (not), no, (low infectivity) yes, but not (not).

Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses.

Of course mild symptoms can be a two edged sword. There could be unrecognized H5N1 circulating in those backyard pigs. And the pigs are in the same backyards as the chickens and ducks and the people.
Sorry, I was referring specifically to pandemic flu which is A type.
 
?? what is "pandemic flu" as opposed to "non pandemic" flu and why are you implying that only Type A is "pendemic flu"....:con2:
Pandemic flu is a new virus that humans have not seen before and is human to human transmission is occurring globally in more than 2 countries.

Seasonal flu occurs annually and is caused by viruses that have circulated before. Only type A influenza viruses cause the pandemics, I'm not sure why but I assume due to their ability to reassort with other influenza viruses.
 
Umm any widespread virus or pathogen can create a pandemic - not just influenza

I think you are getting some things tangled

Let's break it down...


Definition: A global disease outbreak.
A pandemic is a worldwide epidemic that, according to the World Health Organization (WHO), has to meet three conditions:

The microbe infects and causes serious illness in humans. Humans do not have immunity against the virus. The virus spreads easily from person-to-person and survives within humans. Source:
World Health Organization. WHO global influenza preparedness plan. The role of WHO and recommendations for national measures before and during pandemics - March 2005

and it's not restricted to Type A tho that is the most common that kills -

Influenza Type A is the most common and also the scariest of the three influenzas, causing the most serious epidemics in history.

Influenza Type B flu outbreaks also can cause epidemics, but the disease it produces generally is milder than that caused by type A.

Influenza Type C flu viruses, on the other hand, have never been connected with a large epidemic, usually just causing mild respiratory infections similar to the common cold.
 
I wouldn't argue virology with Capsid.

Srsly.

What do you think his avatar is anyway? You do know what capsid is?

Rolfe.
 
Umm any widespread virus or pathogen can create a pandemic - not just influenza

I think you are getting some things tangled

Let's break it down...




and it's not restricted to Type A tho that is the most common that kills -
Was that directed at me? I don't disagree with what you say, so I'm unclear where we are are in knots.
 
Capsid
It just seemed odd that you were constricting the definitions in such a way as you did in the paragraph I quoted.
Only Type A and only influenza

Maybe you were using shorthand? :boggled:

I think that's where a lot of confusion is arising - and the WHO apparently will address the problem.......what the various situations that are announced actually imply.

The level of pandemic index etc does not equate with the level of threat of the particular disease/strain to the individual etc
 

ISF - Join now!

Every member here is approved by hand. No bots, no spam, just people who care about evidence and honest debate.

Membership is free!

Create your free account

Back
Top Bottom